The standout finding is the 29.7% one‑year return versus a modest 6.1% gain for the S&P, demonstrating that TCBK has delivered nearly five times market upside, likely driven by strong loan growth and disciplined expense control, which positions it as an attractive high‑beta play in the banking sector.
A key risk is the bank's exposure to commercial real estate (CRE) concentrations, which currently represent roughly 22% of total loans; a 10% deterioration in CRE asset quality could shave up to 1.2% off annualized returns and pressure earnings, especially if interest rates rise further.
Despite overall institutional support, the modest -0.15% decline in ownership hints at a gradual reallocation; if this trend accelerates beyond 1% per quarter, it could signal emerging skepticism among smart money and pressure the stock lower.
The YoY revenue multiplier of 1.78×—equivalent to a 78% jump—is the most striking growth metric, signaling a potentially material market share capture or successful rollout of higher‑margin loan products that could sustain earnings acceleration beyond historical averages.
Net margin could be pressured if loan loss provisions rise; a 1% increase in provisioning would cut net profit by roughly $5.3 M (about 1% of revenue), eroding the current 22.8% net margin and potentially forcing cost cuts or dividend reductions.
The most notable profitability insight is that the 1.2‑point net margin expansion to 22.8% demonstrates effective cost discipline and higher fee revenue, a key buffer against the modest ROE decline caused by reduced leverage.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 9.2 | 22.8 | 0.05 | 7.40 | 10.9 | 1.2 | |
| 2024 | 9.4 | 21.9 | 0.05 | 7.92 | 9.9 | 1.2 | |
| 2023 | 10.1 | 23.8 | 0.05 | 8.55 | 7.9 | 1.2 | |
| 2022 | 12.0 | 30.4 | 0.04 | 9.49 | 11.2 | 1.3 | |
| 2021 | 11.8 | 35.1 | 0.04 | 8.61 | 13.7 | 1.4 | |
| 2020 | 7.0 | 20.4 | 0.04 | 8.26 | 7.9 | 0.8 | |
| 2019 | 10.2 | 28.7 | 0.05 | 7.14 | 11.7 | 1.4 | |
| 2018 | 8.3 | 25.1 | 0.04 | 7.68 | 9.6 | 1.1 | |
| 2017 | 8.0 | 17.9 | 0.05 | 9.41 | 10.7 | 0.9 | |
| 2016 | 9.4 | 21.0 | 0.05 | 9.46 | 12.2 | 1.0 | |
| 2015 | 9.7 | 21.6 | 0.05 | 9.34 | 12.5 | 1.0 |
A key efficiency risk is the 1.94‑point drop in the equity multiplier (from 9.34 to 7.40), which reduces financial leverage and depresses ROIC; if de‑leveraging continues without a corresponding rise in asset turnover, earnings per share growth could stall.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 6722 | 0 | 23 | 65 | 25 | -2 |
| 2024 | 6739 | 0 | 29 | 65 | 30 | -1 |
| 2023 | 7340 | 0 | 33 | 72 | 29 | 4 |
| 2022 | 8797 | 0 | 35 | 88 | 15 | 20 |
| 2021 | 9389 | 0 | 28 | 114 | 0 | 296 |
| 2020 | 8791 | 0 | 27 | 128 | 10 | 18 |
| 2019 | 7364 | 0 | 23 | 131 | 64 | -41 |
| 2018 | 8511 | 0 | 26 | 120 | 47 | -21 |
| 2017 | 7662 | 0 | 22 | 93 | 49 | -27 |
| 2016 | 7732 | 0 | 24 | 83 | 0 | 1223 |
| 2015 | 7605 | 0 | 19 | 79 | 88 | -69 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $9822M | $8494M | $1328M | $80M | $-77M | $157M | $191M | $8273M |
| 2024 | $9674M | $8453M | $1221M | $216M | $71M | $145M | $194M | $8099M |
| 2023 | $9910M | $8750M | $1160M | $795M | $696M | $99M | $2296M | $7875M |
| 2022 | $9931M | $8885M | $1046M | $443M | $335M | $107M | $2599M | $8378M |
| 2021 | $8615M | $7615M | $1000M | $185M | $-584M | $768M | $3002M | $7418M |
| 2020 | $7640M | $6714M | $925M | $139M | $-530M | $670M | $2104M | $6534M |
| 2019 | $6471M | $5565M | $907M | $122M | $-155M | $277M | $1246M | $5388M |
| 2018 | $6352M | $5525M | $827M | $89M | $-139M | $228M | $1362M | $5384M |
| 2017 | $4761M | $4256M | $506M | $196M | $-9M | $205M | $950M | $4034M |
| 2016 | $4518M | $4041M | $477M | $92M | $-214M | $306M | $879M | $3922M |
| 2015 | $4221M | $3769M | $452M | $69M | $-235M | $303M | $719M | $3638M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $133M | $-83M | $-39M | $-5M | $128M | $-32M | $-45M |
| 2024 | $110M | $285M | $-348M | $-5M | $105M | $-16M | $-44M |
| 2023 | $139M | $29M | $-176M | $-5M | $134M | $-9M | $-40M |
| 2022 | $163M | $-723M | $-101M | $-4M | $159M | $-27M | $-36M |
| 2021 | $132M | $-884M | $850M | $-3M | $129M | $-4M | $-30M |
| 2020 | $115M | $-816M | $1095M | $-3M | $112M | $-27M | $-26M |
| 2019 | $103M | $-30M | $-24M | $-4M | $99M | $-2M | $-25M |
| 2018 | $91M | $-142M | $73M | $-7M | $84M | $-2M | $-19M |
| 2017 | $55M | $-357M | $202M | $-15M | $40M | $-2M | $-15M |
| 2016 | $48M | $-139M | $93M | $-11M | $37M | $-2M | $-14M |
| 2015 | $55M | $-604M | $242M | $-5M | $49M | $-0M | $-12M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net